Connect to share and comment

Flu vaccine more effective for women than men

The flu vaccine is generally less effective for men than for women, scientists said in a study Monday, tracing the effect to higher levels of testosterone that curb the immune response. It has long been known that men are more vulnerable than women to bacterial, viral and parasitic infections, but scientists have never been able to clearly explain why.

Eye care rare among low-income diabetics: study

By Kathryn Doyle NEW YORK (Reuters Health) - Young, low-income diabetics may not know they need annual eye exams, a new study suggests. At a large public hospital where the study was done, few diabetic patients had visited the eye care clinic within the last two years. That's troubling because without regular eye care, diabetics can lose their vision, author Paul MacLennan told Reuters Health. MacLennan led the study at the University of Alabama at Birmingham School of Medicine.

Novo holding firm on U.S. contract prices despite pressure

COPENHAGEN (Reuters) - The loss of a major U.S. contract earlier this year has so far not resulted in any larger customer exodus, world number one insulin maker Novo Nordisk said on Tuesday. The company is encountering growing push back on prices from healthcare insurers and governments, challenging its strategy of increasing prices and charging a premium for innovative medicines.

New data backs promise of long-acting Sanofi insulin

PARIS (Reuters) - An improved version of Sanofi's diabetes drug Lantus is better than the old one at controlling blood sugar levels and comes with fewer hypoglycemic events, new late-stage trial data showed on Tuesday. The treatment is one of several drugs Sanofi is betting on to defend its No.2 spot on the world's $42 billion diabetes market as its superstar product Lantus, the world's most prescribed insulin, will lose patent protection by 2015.

Some breast cancers linked to cholesterol byproduct: study

Some breast cancers linked to cholesterol byproduct: study WASHINGTON, Nov. 28 (Xinhua) -- A byproduct of cholesterol may function like the hormone estrogen to fuel the growth of breast cancer in mice, and perhaps in people, according to a U.S. study. The study, which was released Thursday, shed light on the link between high cholesterol and breast cancer for the first time, especially in post-menopausal women.

Novo to launch mid-stage tests with new diabetes pill

By Ben Hirschler LONDON (Reuters) - Novo Nordisk is about to launch a mid-stage clinical study with a tablet version of a so-called GLP-1 medicine as it steps up the hunt for diabetes pills that can replace injections. The Phase II trial may start as early as next week and will involve approximately 600 patients, Chief Science Officer Mads Krogsgaard Thomsen said on Thursday.

Tennis: Haase tested positive in 2006 - reports

An anti-doping test carried out in 2006 revealed abnormally high levels of testosterone in Dutch tennis player Robin Haase, press reports in the Netherlands revealed on Friday. Haase, 26, explained in the daily Volkskrant that, after undergoing the test, he received a letter from the ATP advising him "to get a lawyer" and indicating that he would have to undergo three more tests in the following two weeks. However, according to Haase, the letter also indicated that "the abnormal level could very well be natural".

Lilly to pump in $700 million to boost insulin making capacity

(Reuters) - Eli Lilly and Co said it will invest more than $700 million to boost its insulin manufacturing capacity in Puerto Rico, France, China and the United States. The company's traditional stronghold has been its diabetes treatments, but the sales of its drugs have been suffering due to increasing competition from companies including Denmark's Novo Nordisk.

Auxilium profit beats estimates as acquisition boosts sales

(Reuters) - Auxilium Pharmaceuticals Inc <AUXL.O> reported a better-than-expected adjusted quarterly profit, boosted by strong drug sales from a recently acquired company, and narrowed its full-year revenue forecast range. Auxilium shares rose about 6 percent in premarket trading. The company said it now expected full-year revenue of $370 million-$401 million compared with $363 million-$405 million estimated earlier.

Testosterone tied to heart risks among older men

By Genevra Pittman NEW YORK (Reuters Health) - Older men who take testosterone are more likely to have a heart attack or stroke or die over the next few years, new research indicates. The study included men who were in their early 60s, on average. Most of them already had blocked heart arteries, high blood pressure, diabetes and other health problems. So it's unclear what the findings mean for younger, healthier men who take testosterone, researchers said.
Syndicate content